xFOREST Therapeutics
xforestx.com
Prescription Drugs
Drug Discovery
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Miyako Capital
Momentum
0/100
no fresh signals
Last sign of life
2 mo ago
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Miyako Capital Overview
xFOREST Therapeutics develops small-molecule therapeutics that target RNA structures of pathogenic genes, leveraging its proprietary FOREST technology suite to identify and optimize RNA-binding compounds. It offers a research platform and drug-discovery services to domestic pharmaceutical companies and is advancing compound optimization platforms to generate clinical drug candidates. The company aims to collaborate with international pharmaceutical partners to expand the global RNA-targeted drug discovery market and accelerate development of RNA-targeted medicines.